Model Number 1550400-15 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Ischemia (1942); Stenosis (2263); Test Result (2695)
|
Event Date 08/05/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
|
Event Description
|
Patient (b)(6).It was reported that on (b)(6) 2019, the patient presented with angina and a severely calcified, 70% stenosed lesion within the proximal left anterior descending (lad) coronary artery.Pre-dilatation and an atherectomy were performed.Following, a 4.0x15mm xience sierra stent (1550400-15, 8101641) was implanted without a device issue reported.The diameter stenosis was reduced to 0% with timi flow iii.On (b)(6) 2020, the patient was hospitalized for known in-stent restenosis which was being medically managed.A recent stress test revealed a small zone of reversibility in the inferior apex, suggesting mild ischemia.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.It should be noted that the reported patient effects of ischemia and stenosis are listed in the xience sierra, everolimus eluting coronary stent system instructions for use, as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined; however, the reported treatments appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
|
Manufacturer Narrative
|
Subsequent information revealed that there was no complaint against this xience sierra device.Based on the information reviewed, there remains no indication of a product quality issue with respect to manufacture, design or labeling.H6: result codes 213 and 114 removed.H6: conclusion codes 22 and 4311 removed.
|
|
Event Description
|
Subsequent to the previous medwatch report, the additional information was obtained: on (b)(6)2020, the patient presented for a renal transplant evaluation.A cardiac catheterization was performed revealing ostial left anterior descending (lad) and distal left main (lm) stenosis.There was a known ostial lad in-stent restenosis of an unspecified stent.Reportedly, the proximal lad 4.0x15mm xience sierra stent remained patent without a device malfunction.This new information revealed that there was no complaint against this device.
|
|
Search Alerts/Recalls
|